Michael Bell, Chairman and Chief Executive Officer, inVentiv Health
Michael Bell, Chairman and CEO of inVentiv Health, brings three decades of business management and operational expertise at leading global services companies to the organization. Seamlessly orchestrating inVentiv’s vast development and commercialization capabilities, he’s responsible for identifying operational efficiencies and strategic synergies across inVentiv to help biopharmaceutical clients’ solve their most challenging problems. Prior to his role as Chairman and Chief Executive Officer, he held the position of inVentiv’s Chief Operating Officer.
Mr. Bell’s an industry veteran who has managed sophisticated global service organizations through every stage of growth. His focus on operational excellence, strategic innovation, and cultivating talent is well regarded in the industry. Prior to joining inVentiv Health, Bell served as Senior Executive Vice President of John Hancock Financial Services, reporting to the Chairman and CEO, doubling the growth rate of the businesses he managed while raising productivity to some of the highest levels in the industry. He also co-founded and helped lead the Monitor Group, where he partnered with companies across the healthcare delivery continuum. Under his leadership, Monitor Group grew rapidly to 1,000 employees and opened 25 offices worldwide. He also has served as a Managing Partner and founder of Monitor Clipper Partners, a private equity firm, where his industry specialties included professional services, procurement outsourcing, and pharmaceutical marketing services.
Mr. Bell received his bachelor's from The Wharton School at the University of Pennsylvania before attending Harvard Business School for a Master of Business Administration. He serves as the Chairman Emeritus of Brigham and Women's Hospital, and previously served as a trustee and the Chair of Brigham and Women's Faulkner Hospital. Mr. Bell also shares his business skills and knowledge as an Adjunct Lecturer at Babson College and holds several other leadership positions with not-for-profit organizations.
Michael A. Griffith, Executive Vice President, inVentiv Health, President, inVentiv Commercial
Michael A. Griffith leads inVentiv Commercial, offering the industry’s only outsourcing model for comprehensive commercialization that provides clients with a critical competitive edge. His segment executes every phase and function in commercialization, including sales teams, market access, public relations, medical communications, adherence programs and more. In this role, he combines his deep financial expertise with extensive knowledge of the pharmaceutical sector drawn from decades of leadership at several successful companies where he accelerated client performance. He’s known for growing his organizations significantly faster than the competition and delivering to promise.
Prior to inVentiv Health, Mr. Griffith was the Chief Executive Officer of Laureate Biopharma, a contract manufacturing organization providing outsourced biologics development and manufacturing services to the biopharmaceutical industry. Mr. Griffith also founded and served as Chief Executive Officer of Aptuit, with the mission of creating and engineering a better drug development process. He also served as Chairman and CEO of ChiRex, the foremost pharmaceutical process development company of its time.
Mr. Griffith started his career in the financial services sector working at both Bankers Trust Company and Credit Suisse First Boston. He’s also served on numerous boards including Repligen Corporation and Centrue Financial Corporation. Mr. Griffith holds a Master of Management from the Kellogg Graduate School of Management at Northwestern University and received his Bachelor of Science degree from the University of Kansas.
Jeffrey P. McMullen, Vice Chairman, inVentiv Health, and Chairman inVentiv Health Clinical
Mr. McMullen has more than forty years of experience in the drug development industry in the United States, Europe, South America and Asia. After nine years with a large pharmaceutical company (now part of Sanofi) where he held positions in clinical, regulatory, and drug metabolism areas, Mr. McMullen joined a small CRO of fifteen people. He helped grow that company to become an international full service operation which was sold to Corning in 1989 and became the foundation of the Covance clinical development business. In 1996, he co-founded PharmaNet where he was President and CEO until joining the board of inVentiv as vice chair.
Eric Green, General Counsel, inVentiv Health
Eric Green is General Counsel of inVentiv Health. In this role, he combines his two decades of health law experience with his deep understanding of the drug development and commercialization industries. Mr. Green was previously a leader at inVentiv Commercial, where he served as lead Counsel overseeing legal and compliance efforts. In his expanded role of General Counsel for inVentiv Health, Mr. Green is responsible for all legal and compliance efforts across all of inVentiv, including SEC issues. He is Secretary to our Board of Directors.
Mr. Green spent almost 15 years working in the healthcare industry prior to joining inVentiv. He served as primary legal support for Quintiles global commercial and consulting businesses, was Quintiles' lead employment law attorney, and sat on their Disclosure Committee. After Quintiles, Mr. Green became counsel at GE Healthcare where he helped launch the Clinical Data services business, which de-identified and aggregated the data from GE's electronic medical record clients for use in health economics and outcomes research. He was also lead research counsel for GE Healthcare IT. All told, Mr. Green has negotiated more than 1000 healthcare related agreements including research, commercialization, joint venture, alliance, royalty, and acquisition agreements.
Mr. Green holds a law degree with High Honors from Rutgers University School of Law – Camden and an MBA from the Cass Business School at the City University of London.
Joseph Solfaro, Chief Information Officer, inVentiv Health
Joe Solfaro, Chief Information Officer of inVentiv Health, has more than 25 years of technology leadership experience. Mr. Solfaro joined inVentiv Health to spearhead overarching transformative change that will fully integrate and streamline the company’s various global lines of business into an even more cohesive, interconnected enterprise. He partners with other members of the executive management team to develop and deploy strategic plans that optimize IT in support of the company’s long-term objectives and vision.
Prior to joining inVentiv Health, Mr. Solfaro was Executive Director of IT Shared Services at Merck & Co., Inc., a leading research-driven healthcare company. At Merck, he served as global steward for all Information Management capabilities at the enterprise level. He focused on service to all lines of business, including Collaboration and Content Management, Global Data Services (Data Quality, Business Intelligence, Database Management), Business Process Management, Integration, Testing and Software Quality Assurance, general application development and support. Mr. Solfaro also oversaw investments in technology strategy, portfolio, development, implementation and support for Merck's Clinical, Biostatistics and Data Management/Operations units globally, as well as R&D shared application service assets.
Mr. Solfaro received a Master of Science degree in Engineering (System) Management from Capitol College in 1996, and a Bachelor of Science in Computer Science from St. Peter’s College in 1986. He is the founder and remains on the Board of ClearEdge Consulting.
Mark Dmytruk, President, inVentiv Health Patient Outcomes
Mark Dmytruk is President of inVentiv Health Patient Outcomes, a sub-segment of the inVentiv Health Commercial segment. He is based at inVentiv Health’s headquarters in Burlington, Massachusetts.
inVentiv Health Patient Outcomes provides a broad range of services relating to patient adherence, patient reimbursement and financial assistance, disease management and cost containment, accountable care solutions, and risk management consulting. inVentiv companies operating under this sub-segment include Adheris Health and inVentiv Patient Access Solutions.
Mr. Dmytruk has extensive experience in the healthcare, life sciences, and diagnostics industries, including emerging and international market development. He joined inVentiv Health from Athena Diagnostics, a leader in molecular diagnostics and personalized medicine, where he was Vice President of Finance and a member of the executive leadership team. Prior to Athena, Mr. Dmytruk was Vice President of Corporate Development at Thermo Fisher Scientific, where he led Thermo Fisher’s merger and acquisition activity worldwide and contributed to revenue growth from $3B to $10B over eight years. Other affiliations include working with Ernst & Young in both Canada and Eastern Europe.
Mr. Dmytruk holds a bachelor’s degree from the University of Alberta in Edmonton, Canada, and an MBA from the Sloan School of Management at MIT.
Kelly Gratz, President
Kelly Gratz’s most recent responsibilities include serving as President of inVentiv Health Selling Accelerators, championing the integration across the Commercial segment. She has a unique blend of experience, holding senior positions within inVentiv Commercial and leading collaborative initiatives across all segments of the business.
Ms. Gratz has been at the forefront of ReAgent™, a proprietary methodology to strategically allocate and optimize commercialization resources. Ms. Gratz also brings direct experience in driving topline growth for brands in an outsourced, risk sharing model as well as operational experience.
Since joining inVentiv Health in 2000, Ms. Gratz has been directly involved in driving multi-channel success for a number of pharmaceutical clients, including Ortho-McNeil Neurologics, Merck, Ethicon, TAP, BMS, Eli Lilly and Company, Genentech, AstraZeneca, GlaxoSmithKline, Ross Products, Takeda, and UCB Pharma.
Prior to inVentiv Health, Ms. Gratz served in an executive management position for Symix Systems, a marketer and developer of e-business software. Previous to Symix, Ms. Gratz spent over 10 years with Ernst & Young in their management consulting group, working with Fortune 500 companies to improve processes and increase overall efficiencies throughout each organization.
Paul Mignon, President, inVentiv Health Selling Solutions
Mr. Mignon successfully leads inVentiv Health Selling Solutions, which encompasses all of the companies that relate to sales teams and sales support services.
In his current role, Mr. Mignon is responsible for the development and execution of comprehensive, customized selling solutions that support many of the major pharmaceutical firms, as well as effectively delivering cross-selling and integrated solutions to clients that include services across the broader inVentiv Health organization.
Mr. Mignon joined inVentiv Health in 2002 when he assumed the leadership role for the sales organization. Since that time, he has expanded the active client roster and significantly diversified their service portfolio.
As a consultative business partner, Mr. Mignon has strengthened and stabilized client relationships by providing innovative products and services to meet the challenges of the dynamic pharmaceutical marketplace.
Mr. Mignon’s depth of experience is built on a successful 14-year career with Johnson & Johnson. During his tenure, he was recognized for many significant accomplishments while holding various leadership roles within the Johnson & Johnson family of companies, including National Sales Director, Sales Training Director, Product Director, and Division Manager.
Mr. Mignon is a graduate of Lafayette College, where he holds a bachelor’s degree in history. He is a member of the editorial board for Product Management Today and serves on the Board of Directors for the Cancer Institute of New Jersey.
Darius Naigamwalla, President, Campbell Alliance
As President of Campbell Alliance, Darius Naigamwalla brings extensive pharmaceutical and biotechnology industry expertise to inVentiv Health. Prior to joining Campbell Alliance, Mr. Naigamwalla was a research associate at the University of Western Ontario. He began his career at Campbell Alliance as a consultant in 2001 and has held roles of increasing responsibility since then, moving up the consulting ranks to become a Practice Leader, Managing Director and, most recently, President.
Mr. Naigamwalla holds a Master of Business Administration from the University of Victoria, a master’s degree in biochemistry and molecular biology from the University of Western Ontario, and a bachelor’s degree in biochemistry from McMaster University.